Melbourne firm CNSDose is providing its technology to progressive US healthcare system Intermountain Healthcare to power an anti-depressant panel for Intermountain's new RxMatch personalised medicine platform.

Intermountain runs a precision genomics laboratory in its home state of Utah and will be offering the technology to its doctors. It will allow them to prescribe anti-depressants guided by a genomic profile of the individual patient.